Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 31

Trial Status

Completed2

Role Distribution

Other Roles2

Activity Timeline

Clinical Trials (2)

NCT00022191Phase 3Completed
Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Studychair

Research Network

Collaboration Network

11 collaborators·31 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Joaquim Bellmunt, MD, PhD

Vall d'Hebron University Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Urinary Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterCancer of Urethra

Worked with same sponsors:

Central European Cooperative Oncology GroupEuropean Organisation for Research and Treatment of Cancer - EORTC+8 more
Collaborated on 1 trial
Similarity Score34%

Stephane Culine, MD

Institut du Cancer de Montpellier - Val d'Aurelle

Moderately Similar
3 trials

Shared therapeutic areas:

Urinary Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterCancer of Urethra

Worked with same sponsors:

Central European Cooperative Oncology GroupEuropean Organisation for Research and Treatment of Cancer - EORTC+8 more
Collaborated on 1 trial
Similarity Score34%

Christoph Zielinski, MD

Allgemeines Krankenhaus - Universitatskliniken

Moderately Similar
1 trials

Shared therapeutic areas:

Urinary Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterCancer of Urethra

Worked with same sponsors:

Central European Cooperative Oncology GroupEuropean Organisation for Research and Treatment of Cancer - EORTC+8 more
Collaborated on 1 trial
Similarity Score34%

David C. Smith, MD

University of Michigan Rogel Cancer Center

Moderately Similar
3 trials

Shared therapeutic areas:

Urinary Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterCancer of Urethra

Worked with same sponsors:

Central European Cooperative Oncology GroupEuropean Organisation for Research and Treatment of Cancer - EORTC+8 more
Collaborated on 1 trial
Similarity Score34%

Malcolm J. Moore, MD

Princess Margaret Hospital, Canada

Moderately Similar
9 trials

Shared therapeutic areas:

Urinary Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterCancer of Urethra

Worked with same sponsors:

Central European Cooperative Oncology GroupEuropean Organisation for Research and Treatment of Cancer - EORTC+8 more
Collaborated on 1 trial
Similarity Score34%

Jose Baselga, MD

Vall d'Hebron University Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Urinary Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterCancer of Urethra

Worked with same sponsors:

Central European Cooperative Oncology GroupEuropean Organisation for Research and Treatment of Cancer - EORTC+8 more
Collaborated on 1 trial
Similarity Score34%

Andreas Boehle, MD

Universitaetsklinikum Schleswig-Holstein - Campus Luebeck

Moderately Similar
1 trials

Shared therapeutic areas:

Urinary Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterCancer of Urethra

Worked with same sponsors:

Central European Cooperative Oncology GroupEuropean Organisation for Research and Treatment of Cancer - EORTC+8 more
Collaborated on 1 trial
Similarity Score34%

Primo N. Lara, MD

University of California, Davis

Related
13 trials

Shared therapeutic areas:

Urinary Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterCancer of Urethra

Worked with same sponsors:

National Cancer Institute (NCI)SWOG Cancer Research Network
Similarity Score18%

Lung-Ji Chang, PhD

Shenzhen Geno-Immune Medical Institute

Related
18 trials

Shared therapeutic areas:

Urinary Bladder CancerSarcoma
Similarity Score12%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

Urinary Bladder CancerSarcoma
Similarity Score12%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT00022191Phase 3StudyChair

Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer

Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Completed
NCT00041249Phase 2StudyChair

Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma

Gastrointestinal Stromal TumorSarcoma
Completed

All 2 trials loaded